Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13,530 JPY | -3.43% | +1.12% | +89.76% |
May. 21 | Jefferies Adjusts TOWA’s Price Target to 16,000 Yen From 12,000 Yen, Keeps at Buy | MT |
Mar. 25 | Towa Pharmaceutical Completes Payment for Director Stock Compensation | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company returns high margins, thereby supporting business profitability.
- The company is in a robust financial situation considering its net cash and margin position.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 57.6 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Semiconductor Equipment & Testing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+89.76% | 2.23B | - | ||
+36.29% | 181B | A- | ||
+75.81% | 42.94B | C- | ||
-16.25% | 28.05B | - | ||
+16.80% | 21.49B | C | ||
+2.89% | 11.69B | B+ | ||
-15.10% | 11.44B | C- | ||
+139.38% | 10.39B | - | ||
+23.82% | 5.66B | - | ||
-21.13% | 4.87B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 6315 Stock
- Ratings TOWA Corporation